BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 45.90
-1.39 (-2.94%)
Nov 21, 2025, 3:04 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 1.04B CNY in the quarter ending September 30, 2025, with 9.19% growth. This brings the company's revenue in the last twelve months to 3.71B, down -7.87% year-over-year. In the year 2024, BGI Genomics had annual revenue of 3.87B, down -11.10%.
Revenue (ttm)
3.71B
Revenue Growth
-7.87%
P/S Ratio
4.74
Revenue / Employee
1.00M
Employees
3,702
Market Cap
17.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | 8.40B | 5.60B | 199.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |
| Shanghai United Imaging Healthcare | 12.20B |